TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05753566

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rezvilutamide
Description: Specifications of 80 mg; orally, once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rezvilutamide
Description: Specifications of 80 mg; orally, once a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Description: Androgen deprivation therapy (ADT), the ADT used by each subject will be determined by the investigator, and the dose and frequency of administration will be consistent with the prescription information

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Description: Androgen deprivation therapy (ADT), the ADT used by each subject will be determined by the investigator, and the dose and frequency of administration will be consistent with the prescription information

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SRT
Description: SRT according to standard of care (66.6-72 grays will be delivered to the bed of prostate ,\~50.4 grays to the pelvis if needed)
Study: NCT06296160

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: A- (Intervention Phase= (Day-1) + (Day-15)~1. Obtain a lung ultrasound after the midweek dialysis session.~2. The 8-zone lung ultrasound method calculates the number of B-line scores.~3. Reduce the dry weight by 500 g if the B-line score is \>0.54/zone (BLS\>5). considered a day one.~4. The dry weight will be reduced only if the arterial blood pressure at the end of the session is BP \>110/60 mmHg and the patient had no hypotension episode during the session.~5. The adjustment of dry weight based on lung ultrasound should not be made on the same day as the standard approach adjustment (Regular monthly clinical standards modification.~6. Check the Blood Pressure 3 times/ day on the non-dialysis following the ultrasound.~7. Check the ambulatory blood pressure for 48 hours (Baseline on day 1 and Follow-up on Day 60).~B - Observational Phase= (Day-30) + (Day-45) + (Day-60)\].
Study: NCT05173428

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking Cessation Program Based on Transtheoretic Model
Description: Conducting motivational interviews based on the transtheoretic model according to the stages of change that individuals are in.
Study: NCT06108648

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lavender essential oil 10%, diluted in 90% olive oil
Description: Lavender chest wrap:~Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth.~Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest.~Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Standard care according to national standards.
Study: NCT05134103

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindbeacon Therapist Guided, Internet Cognitive Behavioral Therapy for Depression
Description: The treatment consists of 11 depression modules delivered approximately once per week (at therapists' discretion) over a period of 12 weeks. Additionally, the therapist typically tailors treatment to client's individual needs by including supplementary modules for a variety of issues such as generalized anxiety, panic, social anxiety, post-traumatic stress, insomnia, pain, and relationships etc. Clients can complete the readings, exercises, and worksheets at any convenient time, using their web-enabled smartphone, tablet, or computer. Access to the modules and all messaging is provided through the secure platform. Messaging is asynchronous meaning participants can message their therapist as often as they choose and expect a response within 1-2 business days. After 12 weeks of active treatment, they will have unguided access (without therapist support) to the treatment materials that were covered for an additional 40 weeks.
Study: NCT06153433

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rosuvastatin Immediate-Release Tablet (IRT) 10mg
Description: Rosuvastatin Immediate-Release Tablet (IRT) 10mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
Description: Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
Study: NCT05767580

Intervention type: OTHER
Intervention: evaluation
Description: The Timed Get Up and Go test to assess dual-tasking, the 4m Walk Test to assess gait, and the Footprint Method to assess cadence

Intervention type: OTHER
Intervention: evaluation
Description: The Timed Get Up and Go test to assess dual-tasking, the 4m Walk Test to assess gait, and the Footprint Method to assess cadence
Study: NCT05487638

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing Education and Counseling Service Provided to Patients by Video Calling on the Phone
Description: Nursing Education and Counseling Services were provided to the patients by video calling on the phone for the problems they may encounter in the postoperative period.
Study: NCT05134103

Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist Control Group
Description: Participants assigned to this arm will wait for 12 weeks before receiving active treatment condition
Study: NCT05318963

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LCAR-AIO cells product
Description: before treatment with LCAR-AIO cells, subjects will receive a conditioning regimen (IV infusion of cyclophosphamide 300 mg/m\^2 and fludarabine 30mg/m\^2 once daily (QD) for 3 days.
Study: NCT04862598

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Oculus Virtual Reality
Description: The patient will receive standard care, augmented with virtual reality. Their post-operative satisfaction score will be recorded.
Study: NCT05655000

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neonatal thymus transplantation
Description: The donor's neonatal thymus vessels will be dissected right after the routinary partial thymectomy. These vessels will be anastomosed into the recipient's penetrating vessels within the radial forearm by using a supermicrosurgical technique. The graft will be explanted at day 14-21 after the procedure.
Study: NCT05632666

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory and expiratory muscle training at a therapeutic intensity
Description: The active treatment group will receive inspiratory muscle training starting at a therapeutic intensity of 30% of maximum inspiratory mouth pressure (PImax) and expiratory muscle training starting at a therapeutic intensity of 30% of maximum expiratory mouth pressure (PEmax) for 4 months.~In the active treatment group, the inspiratory and expiratory threshold (intensity) will be adjusted to the perceived exertion (measured with a Borg scale).

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Inspiratory and expiratory muscle training at a non-therapeutic intensity
Description: The sham-control group will receive the same training protocol as the active treatment group but with a low (10% of PImax and PEmax) and stable non-therapeutic intensity.
Study: NCT05850429

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed
Study: NCT05644613

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise on land
Description: aerobic exercise on land in form of walking on the treadmill

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise in water
Description: aerobic exercises in water in form of walking on the treadmill
Study: NCT04787835

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Forearm nerve block
Description: Local anesthesia will be used to perform a forearm block of the median, radial, and ulnar nerves.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Local anesthetic infiltration
Description: Local anesthesia will be infiltrated at the site of injury
Study: NCT04839211

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Description: Inspiratory muscle training will be performed three sessions per week as one supervised and two unsupervised for 8 weeks using an inspiratory muscle training device (PowerBreath). The inspiratory muscle training session will consist of 7 cycles including a 2:1 ratio of work and rest interval. Resistance will be adjusted to the highest tolerable load and will be gradually increased.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham inspiratory muscle training
Description: Sham inspiratory muscle training will be performed three sessions per week as one supervised and two unsupervised for 8 weeks using an inspiratory muscle training device (PowerBreath). The inspiratory muscle training session will consist of 7 cycles including a 2:1 ratio of work and rest interval. Resistance will be adjusted to the unloaded.
Study: NCT06103227

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone 5Mg
Description: Prednisone administered for three weeks. If pregnant women weighs less than 90 kg , she will receive prednisone on altering days instead of every morning for pregnant women weighing more than 90 kg.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone 5Mg
Description: Prednisone administered for three weeks. If pregnant women weighs less than 90 kg , she will receive prednisone on altering days instead of every morning for pregnant women weighing more than 90 kg.
Study: NCT05581095

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating Self-Help Program
Description: 10-week exposure to mindful eating principles and practices outlined in the Eat What You Love, Love What You Eat for Binge Eating book

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindful Eating Self-Help Program
Description: 10-week exposure to mindful eating principles and practices outlined in the Eat What You Love, Love What You Eat for Binge Eating book

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Eating Smartphone Application (Am I Hungry? Virtual Coach)
Description: 10-week exposure to using a mindful eating mobile phone application daily.
Study: NCT04688918

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Retrolaminar block
Description: A high-resolution 5-12 MHz linear probe with a sterile cover will be used to perform the block. The patient will be placed in a prone position with a pillow under the chest. The spinous process of the fourth thoracic vertebrae will be identified and marked. Under complete sterilization, the ultrasound high frequency linear probe will be placed in a para-sagittal position, just lateral to the spinous processes of thoracic vertebra, to identify the vertebral lamina. A 50 mm 22-gauge needle will be inserted in an in-plane technique from cranial to caudal direction and will be advanced till hitting the laminae of fourth thoracic vertebrae and then we will try to inject the local anesthetic, if the resistance to injection is very high, hence we will withdraw the needle slowly and its tip will be kept in its position immediately after disappearance this high resistance. Bupivacaine 0.25%, 0.4mL/kg will be injected.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: paravertebral group
Description: A high-resolution 5-12 MHz linear probe with a sterile cover will be used to perform the block. The patient will be placed in a prone position with a pillow under the chest. The transverse process of the fourth thoracic vertebrae will be identified and marked. Under complete sterilization, the ultrasound high frequency linear probe will be placed in a para-sagittal position, just lateral to the spinous processes of thoracic vertebra, to identify the vcostotransverse ligament, 0.4mL/kg will be injected
Study: NCT05278884

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced Cardiac Life Support Training
Description: Advanced Cardiovascular Life Support (ACLS) is a resuscitation course to teach recognition and treatment of cardiopulmonary arrest in patients.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vital Anesthesia Simulation Training
Description: The Vital Anesthesia Simulation Training (VAST) Course focuses on core clinical practices and non-technical skills needed to respond to the most common urgent and emergent clinical challenges found in hospitals in resource-limited settings like Rwanda.
Study: NCT06369844

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pressure injury education
Description: Pressure injury education will be provided to participants in the intervention group in three separate sessions covering the topics of Pressure Injury Definition and Classification, Risk Assessment, Prevention, and Care.
Study: NCT06194695

Intervention type: PROCEDURE
Intervention: drug eluting beads-transcatheter arterial chemoembolization
Description: transcatheter arterial chemoembolization with doxorubicin embedded eluting beads- was performed every 3 weeks through the tumor feeding arteries.

Intervention type: DRUG
Intervention: envatinib plus anti-PD(L)1
Description: oral use of lenvatinib plus intravenous injection of anti-PD(L)1 antibodies. Anti-PD-L1 antibodies includes duravalumab, atezolizumab, or envolizumab, and anti-PD1 antibodies include pembrolizumab, nivolumab, camrelizumab, tislelizumab, sintilimab, or toripalimab.
Study: NCT06357455

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cell Salvage Autotransfusion: SAME™ device
Description: * Intervention studied: processing of salvaged blood using the SAME™ autotransfusion device~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Treatment group.~All perioperative measures will be performed according to international, national and in-house standards.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cell Salvage Autotransfusion: Autolog™ device
Description: * Intervention studied: processing of salvaged blood using the Autolog™ (Medtronic) autotransfusion device (in-house standard device).~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Control group~All perioperative measures will be performed according to international, national and in-house standards.
Study: NCT05813990

Intervention type: OTHER
Group type: OTHER
Intervention: recostructive ear surgery
Description: recostructive ear surgery in pediatric population
Study: NCT05982366

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: distal radial artery acess side
Description: coronary procedure (coronary angiography and/or coronary angioplasty) by the distal radial artery in the anatomical snuffbox area

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional radial artery acess side
Description: coronary procedure (coronary angiography and/or coronary angioplasty) by the forearm radial artery in the anatomical snuffbox area
Study: NCT04705389

Intervention type: OTHER
Group type: OTHER
Intervention: Samples
Description: blood samples
Study: NCT03040856

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Alpha Linolenic Acid
Description: Alpha Linolenic Acid enriched diet

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega 3 enriched diet ( DHA+EPA)
Description: Omega 3 (DHA+EPA) supplementation enriched diet

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules containing olive oil
Study: NCT05492513

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Grade 1 CI Therapy +Sensory Components
Description: All participants will receive Grade 1 CI Therapy + Sensory Components over a two-week period of time. The treatment intervention will include all CI Therapy treatment strategies including: 1) supervised motor training in the form of shaping with repeated trials and task practice for 1.5 hours per day for 5 weekdays for 2 weeks 2) a behavioral Transfer Package (TP) will be employed to aid carry-over of skills gained by the participant in the laboratory to the life situation 3) each participant will wear a mitt on the less-affected hand for most of their waking hours to encourage use of the more-affected hand 4) participants will be given home assignments to be carried out for at least 30 minutes each day. Sensory component strategies will be added to stimulate sensory input through the more-affected arm and hand as well as to train sensory discrimination skills.
Study: NCT06044805

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chloroquine
Description: Total of 25mg base per kg over 3 days (10 mg base/kg on Days 0 and 1, 5 mg base/kg on Day 2)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine
Description: Primaquine: 7.5 mg base tablet. Medication given as 0.25mg/kg daily for 14 days.
Study: NCT05773261

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MobilLINK TrabecuLINK cup
Description: THA with MobilLINK TrabecuLINK cup and LCU stem

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pinnacle Gription cup
Description: THA with Pinnacle Gription cup and Coral stem
Study: NCT06480175

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cervical plexus block
Description: patients will receive cervical radiofrequency ablation on both sides then after 2 weeks they will be readmitted and will receive superficial cervical plexus block on one side only
Study: NCT06157320

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Shen-Fu
Description: Within 24 hours of sepsis diagnosis, patients received a daily intravenous infusion of 100 ml of Shenfu Injection for a continuous duration of 7 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Norepinephrine (NE)，antibiotics，fluid resuscitation
Description: empirical antimicrobial treatment (which is promptly administered after microbial tests), fluid (crystalloids) replacement (to be established according to fluid tolerance and fluid responsiveness), and vasoactive agents (e.g., norepinephrine (NE)), which are employed to maintain mean arterial pressure above 65 mmHg and reduce the risk of fluid overload
Study: NCT05363761

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Neurotronic Infusion Catheter
Description: Denervation of renal and common hepatic arteries by ethanol ablation with the Neurotronic Infusion Catheter
Study: NCT06417372

Intervention type: DIAGNOSTIC_TEST
Intervention: intraoperative fluorescent staining combined with microscopy
Description: Through the modified formulation of sodium fluorescein and methylene blue, the surface of the suspected cut edge of the patient's glioma was stained intraoperatively, and the surgical microscope image acquisition and processing system was used to determine whether the cut edge of the surgically resected tissue was positive or not.
Study: NCT05096442

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GENOSS® DCB
Description: Drug Coated Balloon

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SeQuent® Please NEO
Description: Drug Coated Balloon
Study: NCT04784650

Intervention type: OTHER
Group type: OTHER
Intervention: Pre-dialysis population
Description: Pre-dialysis population, consisting of both Diabetes Mellitus (DM) and non-DM patients
Study: NCT05424328

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ALTF (Anterolateral thigh flap) with preoperative virtual planning
Description: In this study group, using preoperative CTs (head \& neck and thigh ) to virtually plan a guide that can be used during the surgery, this guide will determine the design and dimensions of the Alt flap to be harvested and restore the defect left on the tongue due SCC resection and hemi glossectomy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ALTF (Anterolateral thigh flap) with conventional method
Description: ALTF (Anterolateral thigh flap) will be harvested with conventional method which depends on surgeon's own experience in determining the flap design and dimensions needed to reconstruct and restore the defect left on the tongue due SCC resection and hemi glossectomy.
Study: NCT06061978

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: left bundle branch of His pacing
Description: left bundle branch of His pacing

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: left bundle branch of His pacing
Description: left bundle branch of His pacing

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: right ventricular pacing
Description: right ventricular pacing

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: right ventricular pacing
Description: right ventricular pacing
Study: NCT06698497

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Communication Campaign
Description: A social media vaccine communications campaign is deployed once increasing amounts of SARS-CoV-2 RNA are identified in the New York State wastewater surveillance network. The social media campaigns on Facebook, Instagram, and NextDoor social media platforms will run for 11 weeks. The campaign disseminates information about the wastewater surveillance network and vaccination (not COVID-19 specific) to residents in intervention counties. These social media platforms not only allow for quick and cost-effective exposure, but also allow for participation and interaction with participants. The campaign ads include a call-to-action link to the New York State wastewater surveillance network webpage which has information and links regarding vaccines for respiratory transmitted pathogens (COVID-19, influenza, and RSV) and how to schedule an appointment.
Study: NCT06698718

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periodontal basic treatment
Description: Accept periodontal basic treatment
Study: NCT06698913

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rotational Therapy
Description: Sample1- Ventilator settings where adjusted with PEEP based on BMI, followed by a 2 cmH2O increase and 20 minutes in a lateral position at 30 degrees for lung recruitment for both sides. And at the end were subjected to an alveolar recruitment maneuver with pressure increases up to a plateau pressure of 45 cmH2O. Sample2- A recruitment maneuver followed by PEEP titration is performed, selecting the PEEP that is above the crossing point between the collapse and hyperdistension curves provided by EIT. And the the PEEP-ARDSNet will be selected according to the low PEEP-FIO2 table from the ARDSNet protocol. Observations are made at 4 and 24 hours, with PEEP at 24 hours adjusted to the level identified by EIT.
Study: NCT06365905

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-Interventional Study